Application no. and date | 06121895.4 (espacenet) (Federated) (European Patent Register), 20010119 | Patent/reg. no. and date | DK/EP 1741446, 20080206 | Publication date | 20070110 | Priority no. and date | US 489234, 20000121, US 619262, 20000719 | EP pub. no. and date |
EP 1741446 20070110 | Effective date | | Applicant/owner | Novartis Pharma AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | 132873 | Inventor | Balkan, Börk, 20 Northwood Road
Madison, NJ 06443, US, Holmes, David Grenville, Holeeholzweg 76
4102, Binningen, CH, Villhauer, Edwin Bernard, 20 Dorothy Drive
Morristown, NJ 07960, US, Hughes, Thomas Edward, 89 Wilson Road
Concord, MA 01742, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4025 (2006.01) , A61K 31/44 (2006.01) , A61K 31/505 (2006.01) , A61K 45/06 (2006.01) , A61P 3/10 (2006.01) | Title | Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2008 00025 | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|